Clinical Trials · NCT04641312
A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 67
- Start date
- Nov 2020
- Locations
- 2 sites, Germany
- Primary endpoint
- Number of Participants with One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration